Two competing drugs are focusing on weight loss as serious medicine and are targeting selected physicians in their promotional efforts: Abbott has dropped consumer advertising in favor of promoting Meridia to physicians and Roche has reduced its field force size and will de-emphasize sales efforts to primary care in favor of more targeted physicians. Roche ran into trouble when it used an unbranded broadcast ad to support its Xenical weight-loss program, which the FDA found to ...

cialis - check it

tramadol - check it

viagra - check it

levitra - check it

phentermine - check it

xenical - check it